P ulmonary artery sarcoma (PAS) is a rare primary malignancy of pulmonary artery with poor prognosis. The main manifestation of PAS is a filling defect in pulmonary artery on computer tomography pulmonary angiography (CTPA) or magnetic resonance imaging (MRI) mimicking pulmonary thromboembolism (PTE) (1). [ F-FDG uptake (3). Blackmon et al. (4) has suggested that in patients who do not respond to the initial thrombolysis or anticoagulation, further investigation with gadolinium-enhanced MRI should be undertaken. Currently, most imaging findings were evaluated with CT or PET, but the characteristics of PAS and the differentiation of PAS and PTE on multiparametric MRI remain unclear. Therefore, our purpose was to observe MRI findings of PAS and to determine the MRI findings that allow its differentiation with PTE.
ticoagulation in other hospitals. However, since there was no release of clot burden on CTPA, no relief of clinical symptoms, and lack of response to thrombolysis or anticoagulation, they were referred to our hospital for further diagnosis and treatment. Patients underwent pulmonary MRI 3-10 days before they were referred for surgery or biopsy. The pathologic diagnosis was made in eight patients by surgery and in the remaining three patients by pulmonary angioscopy with transvenous catheter suction biopsy. Sixteen patients who did not undergo pulmonary MRI or did not receive pathologic diagnosis were excluded from the study.
Imaging protocol
Pulmonary artery MRI was performed with a 3.0 T scanner (Tim Trio, Siemens Healthcare) using dedicated cardiac software with a body-flex receiver coil and vectocardiogram triggering. After scout imaging with transversal T2-weighted half-fourier acquisition single-shot turbo spin echo (HASTE) sequence, the unenhanced scan protocol consisted of the following sequences: the transversal, coronal and/or oblique T1-weighted imaging (TR/ TE, 750/28 ms; flip angle, 180 o ; bandwidth, 305 Hz/Px, FOV, 340×340 mm; slice thickness, 5 mm; matrix, 256×256; acceleration factor, 2), T2-weighted imaging (TR/TE, 745/72 ms; flip angle, 180 o ; bandwidth, 235 Hz/Px; FOV, 340×340 mm; slice thickness, 5 mm; matrix, 256×256; acceleration factor, 2) and fat-suppressed T2-weighted imaging (TR/TE, 2200/100 ms; flip angle, 140 o ; bandwidth, 300 Hz/Px; FOV, 340×340 mm; slice thickness, 5 mm; matrix, 256×256; acceleration factor, 2). Then, the transversal diffusion weighted images (DWI) were obtained using navigated interleaved multishot echo planar imaging (EPI) sequence with fat suppression (b, 0 and 800 s/mm 2 ; TR/TE, 4000/66 ms; flip angle, 90 o ; bandwidth, 2012 Hz/Px; FOV, 350×350 mm; slice thickness, 5 mm; matrix, 128×128; acceleration factor, 2). Next, dynamic breath-hold 3D gadolinium-enhanced MRI sequences were acquired with transversal T1-weighted imaging volume interpolated breath-hold examination (VIBE) sequence with fat suppression (TR/TE, 3.48/1.28 ms; flip angle, 9 o ; bandwidth, 460 Hz/Px; FOV, 360×360 mm; slice thickness, 5 mm; matrix, 320×320; acceleration factor, 2) after gadopentetate dimeglumine (Magnevist, Schering) was applied at 0.2 mmol/ kg bodyweight at a rate of 2 mL/s using a power injector (Mallinckrodt).
MRI analysis
MRI findings regarding embolus distribution, morphologic characteristics, DWI, preand postcontrast intensity were reviewed by two radiologists, who were blinded to other clinical and pathologic information. A third radiologist evaluated the findings when the two radiologists were not in consensus about their diagnosis. Intensity of the lesion on unenhanced MRI images (categorized as hyperintensity, mild hyperintensity, isointensity, mild hypointensity and hypointensity) was compared with the intensity of the chest wall. Apparent diffusion coefficient (ADC) values were measured for each clearly demarcated lesion on Syngo workstation (syngoMMWP, Siemens AG) by drawing a circular region of interest (ROI) into pulmonary arterial lesions. Enhancement was evaluated for each clearly demarcated lesion by drawing a circular ROI into pulmonary arterial lesions by Mean Curve, commercial software on Syngo workstation.
Statistical analysis
Quantitative data were expressed as mean±standard deviation (SD) and/or median value, unless otherwise specified. 
Results
Clinical characteristics of the patients are summarized in Table 1 . After surgery, six cases (male/female, 5/1; median age 46 years; range, 36-69 years) were pathologically confirmed as PAS and the remaining five cases (male/female, 2/3; median age, 47 years; range, 40-50 years) as organized thrombus, which meant chronic PTE. Age (U=13.0, P = 0.792), gender (P = 0.242), and body mass index (U=11.5, P = 0.485) were not significantly different between chronic PTE and PAS patients. In our hospital, the median of D-dimer of chronic PTE patients was comparable to that of PAS patients (U=10.0, P = 0.429). There was no significant difference on N-terminal pro-brain natriuretic peptide (NT-proBNP) between the two groups (U=11.0, P = 0.537). The median duration from initial symptom to pathologic confirmation was nine months (range, 2-25 months). Table 2 shows the distribution and morphologic characteristics of the lesions. The distribution of PAS and chronic PTE lesions were similar (χ 2 =6.160, P = 0.188), but the frequency of the main pulmonary artery involvement was significantly higher in the PAS group (P = 0.045). Six PAS lesions and three chronic PTE lesions manifested as columnar filling defects in the pulmonary artery (Figs.  1-3 ). The wall eclipsing sign (Figs. 1 and 3 ) was observed in five PAS and two chronic PTE lesions, with no significant difference between PAS and chronic PTE (P = 0.242). The proximal margins of three PAS ( Fig. 2 ) and four chronic PTE (Fig. 3 ) lesions were smooth, while those of the remaining three PAS lesions ( Fig. 1 ) and one chronic PTE lesion were irregular. Shape of the margin was not significantly different between PAS and chronic PTE (P = 0.545). In three PAS patients, MRI showed intraluminal filling defects in the main pulmonary trunk, left pulmonary artery or right pulmonary artery extending to the segmental and sub-segmental arteries with local aneurysmal dilatations, which we termed the sign of grape-like appearance (Fig. 2d) , However, the sign of grape-like appearance was comparable in PAS and chronic PTE (P = 0.240). In addition, the frequency of pleural effusion in PAS was significantly more than chronic PTE (P = 0.015).
Intensity of PAS and chronic PTE lesions on MRI are shown in Table 3 . On T1-weighted (P = 0.424) and T2-weighted imagings (χ 2 =1.118, P = 0.561) lesion intensity was comparable between chronic PTE and PAS.
Main points
• MRI findings of pulmonary artery sarcoma include hyperintense filling defect in the main pulmonary artery on fat suppressed T2-weighted and diffusion-weighted imaging and contrast enhancement.
• The grape-like appearance in distal pulmonary artery and cardiac invasion on MRI are the specific findings for pulmonary artery sarcoma.
On fat-suppressed T2-weighted imaging, three chronic PTE lesions were isointense, while five PAS lesions were hyperintense, and the remaining one was mildly hyperintense. On fat-suppressed T2-weighted imaging, intensity of the lesions were significantly different between chronic PTE and PAS (Fig. 3) , while five PAS lesions were significantly enhanced (Figs. 1 and 2) (P = 0.015).
As shown in Table 4 , among MRI findings that were tested for their ability to diagnose PAS, AUC was significantly higher than 0.5
Pulmonary artery sarcoma vs. pulmonary thromoboembolism differentiation by multiparametric MRI • 17 for the main pulmonary artery involvement, hyperintensity on fat-suppressed T2-weighted imaging and DWI, contrast enhancement, and pleural effusion. Moreover, other MRI findings including the sign of grape-like appearance and cardiac invasion were 100% specific to PAS.
Discussion
In this study, we observed multiparametric MRI findings of PAS and the differentiation of PAS and PTE. Hyperintense filling defect invading the main pulmonary arteries on fat-suppressed T2-weighted imaging, contrast enhancement, and grape-like appearance in distal pulmonary arteries were the major findings of PAS on MRI.
Previous studies demonstrated that PAS typically affects middle-aged people, with a slight propensity for women (1, 5) . In our study, PAS also mainly affected middle-aged people, but there was no significant difference in age between PTE and PAS patients. Moreover, most of our patients with PAS were men. Since PAS is quite difficult to distinguish from PTE based on clinical symptoms and CT or magnetic resonance angiographic findings, we used multiparametric MRI. In order to reduce the influence of cardiac and respiratory motion on image quality, multiparametric MRI including vectocardiogram triggering and breath-hold on T2-weighted imaging, T2-weighted imaging, and fat-suppressed T2-weighted imaging were used instead of magnetic resonance angiography in this study. Moreover, Navigator echo technique used in DWI can effectively track rigid-body motion of limited amplitude and promise to obtain the same slice (6) .
The filling defect occupying the main or proximal pulmonary arteries was reported to be a specific finding of PAS (7-9). In the current study, we found the filling defect in the main pulmonary artery to be a specific sign of PAS, which was not seen in any patients with PTE. PAS is reported as a disease of unilateral distribution whereas PTE is reported as a disease of bilateral distribution (10, 11) . However, the distributions in PAS and PTE in our cases were not different. The grapelike appearance was a result of intraluminal filling defects in the main pulmonary artery trunk, left pulmonary artery or right pulmonary artery extending to the segmental and sub-segmental arteries, which had local aneurysmal dilatations. This sign was 100% specific to PAS; we believe this feature is related to the malignant nature of sarcoma, which grows rapidly and invades the segmental and sub-segmental pulmonary arteries. Although irregular margin was thought to be a feature of the malignant tumor, the proximal margin of both PAS and PTE could be smooth. Thus, it was not feasible to differentiate PAS from PTE using this feature. On CTPA, Gan et al. (12) suggested that the wall eclipsing sign is pathognomonic for PAS. They defined three manifestations of the wall eclipsing sign as: i) almost full occupation of the lumen of the pulmonary trunk, left pulmonary artery, or right pulmonary artery by a low density mass; ii) protrusion of the proximal end of this mass towards the right ventricular outflow tract; iii) eclipsing of one or both walls of the pulmonary trunk, left pulmonary artery, or right pulmonary artery by this lesion. On MRI, three PAS lesions and two PTE lesions demonstrated full occupation of the lumen of the pulmonary trunk, and the other two PAS lesions affected the pulmonary valves. Our ROC analysis suggests that the wall eclipsing sign on MRI is not a reliable sign for differentiating PAS and PTE. We believe this is because the spatial resolution of pulmonary arterial wall is better on MRI than on CT. MRI has been used to differentiate benign from malignant portal vein thrombus (13) and cardiac tumor (14) . In our cases, both PAS and PTE lesions showed mild hyperintensity or isointensity on T1-and T2-weighted imaging. We do not think that T1-and T2-weighted imagings are helpful to differentiate PAS from PTE. On fat-suppressed T2-weighted imaging, PAS lesions were hyperintense; however, PTE could display different signal intensities. According to our ROC analysis, hyperintensity on fat-suppressed T2-weighted imaging may be a helpful sign for identifying PAS. We speculate that the intensity of PTE on fat-suppressed T2-weighted imaging is related to various stages of thrombus (15) . Characterization of tissue as benign or malignant by DWI is enabled by restricted water molecule diffusion in the malignant tissue, yielding lower ADC values than those of benign lesions (16) . One study reported that ADC values of malignant portal vein thrombus (PVT) were significantly lower than bland PVT (13) , while another study suggested that DWI was not reliable to differentiate benign PVT from malignant PVT (17) . In the current study, most PAS lesions were hyperintense and PTE lesions were mildly hypointense on DWI. ROC analysis suggested that hyperintensity on DWI could be a sign of PAS. However, there was substantial overlap of ADC values between PAS and PTE. This result is in agreement with Sandrasegaran et al. (13) who found that ADC value of PVT is not a significant parameter to differentiate PVT from benign PVT. We
Pulmonary artery sarcoma vs. pulmonary thromoboembolism differentiation by multiparametric MRI • 19 images (d, e) show that the lesion filled the right upper lobe pulmonary artery along its course giving it a grape-like appearance (blue arrow); the lesion is significantly enhanced (e). Histopathology (f) demonstrates an abundance of malignant spindle cells with high cellularity and a high nuclear/cytoplasmic ratio (HE staining, ×200). speculate that the lack of difference in the ADC values between PAS and PTE may be due to gradient-echo imaging, clot structure, T2 blackout effect, or the small sample size in this study. Some studies demonstrated that contrast enhancement of PVT on MRI was able to discriminate between malignant and bland PVTs (18, 19) . However, another study suggested that both PAS and chronic PTE could be enhanced (20) . In our study, contrast enhancement was observed in five of six PAS lesions, which is in agreement with the study by Cox et al. (8) . However, one PAS lesion did not show obvious enhancement. Since sarcoma could coexist with thrombus, we think that enhancement of PAS depends on pathologic type and the components of tumor cells and thrombus tissue. In contrast-enhanced MRI, none of the PTE lesions were significantly enhanced, as compared with PAS. ROC analysis revealed that the enhancement on MRI could be a reliable finding of PAS. There were two types of sarcomas; however, we failed to compare their different MRI findings and correlate MRI and pathologic findings for such small number of cases included in this study. Our study has several limitations. The first limitation is its small sample size; thus, some MRI findings were not statistically different between PAS and PTE, such as cardiac invasion and the grape-like appearance in the involved distal pulmonary artery, although its specificity for PAS is 100%. Second, we only used a b value of 800 s/mm 2 ; therefore, how many b values are needed and which one should be better to discriminate PAS and PTE remain unknown. Third, only chronic PTE patients were compared with PAS; MRI findings of acute PTE and its differentiation with chronic PTE and PAS need further observation.
In conclusion, the most important MRI findings of PAS were hyperintense columnar filling defects occupying the lumen of the main or the proximal pulmonary artery on fat-suppressed T2-weighted imaging, contrast enhancement, and grape-like appearance in segmental pulmonary arteries. Although PAS lesions are easily misdiagnosed as PTE, the above MRI findings may be suggestive of PAS. 
